Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Anti-infection
    (4)
  • Virus Protease
    (4)
  • Antibiotic
    (1)
  • Antifungal
    (1)
  • Antiviral
    (1)
  • Apoptosis
    (1)
  • P2Y Receptor
    (1)
  • Reactive Oxygen Species
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

junin

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
ST-193
T13006489416-12-8
ST-193 is a potent inhibitor of broad-spectrum arenavirus(Guanarito, Junin, Lassa and Machupo virus with IC50 values of 0.44, 0.62, 1.4 and 3.1 nM, respectively).
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
(E)-LHF-535
T111382449213-57-2
(E)-LHF-535, the E-isomer of LHF-535, is an antiviral agent with EC50 values of <1 μM for Lassa, Machupo, and Junin viruses, and 1-10 μM for VSVg virus [1].
  • $1,520
8-10 weeks
Size
QTY
LHF-535
T11138L1450929-77-7
LHF-535 is an antiviral compound. It has EC50s of <1 μM, <1 μM, <1 μM, and 1-10 μM for Lassa, Machupo, Junin, and VSVg virus, respectively.
  • $39
In Stock
Size
QTY
Verrucarin J
Muconomycin B
T692254643-58-7
Verrucarin J (Muconomycin B), derived from the Myrothecium fungus family, effectively generates reactive oxygen species (ROS) to induce apoptosis in various cancer cell lines, including A549, HCT 116, and SW-620. Besides its anticancer properties, it exhibits antifungal activity against Candida albicans and Mucor miehei. Furthermore, it notably inhibits the arenavirus Junin (JUNV) yield with an IC 50 of 1.2 ng mL.
  • $1,520
6-8 weeks
Size
QTY
EICAR
T71291118908-07-9
EICAR is a drug which acts as an inhibitor of the enzyme IMP dehydrogenase. It is a nucleoside derivative which has both anti-cancer and antiviral effects, and was originally developed for the treatment of leukemia, but was unsuccessful in human clinical trials. It has broad spectrum antiviral effects with activity against vaccinia virus, Semliki forest virus, Junin virus, reovirus, influenza, measles virus and respiratory syncytial virus among others, although it is not active against SARS. This useful spectrum of activity means that EICAR and related derivatives continue to be investigated for the treatment of viral diseases.
  • $3,020
10-14 weeks
Size
QTY
ATP-γ-S tetrasodium
Adenosine 5'-(γ-thio)-triphosphate tetrasodium, ATPγS tetrasodium, Adenosine-5'-O-(3-thiotriphosphate) tetrasodium
T8382788453-52-5
ATP-γ-S tetrasodium (Adenosine-5'-O-(3-thiotriphosphate) tetrasodium) is a purinergic P2Y11 receptor agonist and ATP analog that induces inositol phosphate accumulation, induces insulin secretion from MIN6 pancreatic islet β-cells, and induces an increase in intracellular calcium concentration. ATP-γ-S tetrasodium inhibits the induction of the Junin virus. Junin virus-induced increase in the level of mRNA encoding bone morphogenetic protein 6 (BMP6) reduces particle-forming units (PFUs) in Junin virus-infected primary rat osteoblasts.
  • $398
35 days
Size
QTY